News for 'Sun Pharma'

Tylenol row may not hit India's pharma exports

Tylenol row may not hit India's pharma exports

Rediff.com29 Sep 2025

Amid controversy over USPresident Donald Trump's comments linking the use of Tylenol and other related paracetamol products by pregnant women to autism in children, experts and industry executives say that since India's export of the drug to the US is less, it will hardly affect the country's pharma exports to America.

Sensex, Nifty tank nearly 1% on selling in pharma, IT shares

Sensex, Nifty tank nearly 1% on selling in pharma, IT shares

Rediff.com26 Sep 2025

Most pharma shares dropped, dragging the BSE Healthcare index down by 2.14 per cent after Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1. Wockhardt shares tanked 9.4 per cent.

Rupee's record low, crude prices pull Indian markets lower

Rupee's record low, crude prices pull Indian markets lower

Rediff.com19 May 2026

Indian stock markets concluded Tuesday's trading session lower, reversing intraday gains due to late-session selling in blue-chip stocks like HDFC Bank and Reliance Industries. The decline was primarily driven by the Indian rupee hitting a new record low against the US dollar and elevated global crude oil prices, compounded by geopolitical uncertainties.

Stock markets today: Sensex, Nifty50 in red amid volatile trade

Stock markets today: Sensex, Nifty50 in red amid volatile trade

Rediff.com7 May 2026

Indian benchmark indices Sensex and Nifty experienced volatile trade, declining in early deals before fluctuating, as investors reacted to unabated foreign fund outflows and rising geopolitical uncertainties, particularly in West Asia.

AI is fast becoming central to how drugs will be discovered

AI is fast becoming central to how drugs will be discovered

Rediff.com25 Feb 2026

Artificial intelligence (AI) is no longer a side conversation for Indian pharma. It is fast becoming central to how drugs will be discovered, made, and supplied. Along with that shift comes a sharper focus on innovation, on the one hand, and quality and trust, on the other.

Stock Markets Today: Sensex, Nifty50 React to Global Cues as US-Iran peace talks fail

Stock Markets Today: Sensex, Nifty50 React to Global Cues as US-Iran peace talks fail

Rediff.com13 Apr 2026

Equity benchmark indices Sensex and Nifty tumbled in early trade on Monday, with the 30-share BSE Sensex falling 1,613.09 points and the 50-share NSE Nifty plunging 495 points, as the failure of US-Iran negotiations heightened concerns of a prolonged conflict driving crude oil prices sharply higher. Track Sensex, Nifty50 movement and key market drivers for April 13, 2026.

Pharma cos may see short-term price blip: Ind-Ra

Pharma cos may see short-term price blip: Ind-Ra

Rediff.com27 Aug 2025

Any potential tariffs on pharmaceutical imports into the US are unlikely to impact the credit profiles of Indian firms except for a short-term pricing blip, according to a report by India Ratings and Research (Ind-Ra). The report stated that the US generics market contributes around 35 per cent to the total revenue of the leading Indian pharma firms.

Can MFN Pricing Reshape India-US Pharma Equation?

Can MFN Pricing Reshape India-US Pharma Equation?

Rediff.com5 Jun 2025

US accounts for a large part of revenue for top Indian pharma companies like Gland Pharma (54 percent), Dr Reddy's (53 per cent), and Aurobindo Pharma (48 per cent).

Stock Markets Today: Sensex, Nifty50 Down on Strait of Hormuz Tensions, Weak Rupee

Stock Markets Today: Sensex, Nifty50 Down on Strait of Hormuz Tensions, Weak Rupee

Rediff.com5 May 2026

Indian equities on Dalal Street saw volatility as global market trends and weak rupee impacted investor sentiment. Track Sensex, Nifty50 movement and key market drivers for May 5, 2026.

Sensex Jumps 919 Points as Financial Stocks Lead Market Rebound

Sensex Jumps 919 Points as Financial Stocks Lead Market Rebound

Rediff.com10 Apr 2026

Indian benchmark indices Sensex and Nifty surged over 1 per cent, with the Sensex jumping 918.60 points, driven by strong buying in banking and financial counters and a positive trend in global equities, fuelled by hopes of easing West Asia tensions.

India-EU FTA: Textiles, pharma, engineering to get major boost

India-EU FTA: Textiles, pharma, engineering to get major boost

Rediff.com26 Jan 2026

Textiles, pharmaceuticals, chemicals, engineering goods, gems and jewellery exports will receive a boost from the free trade agreement between India and the 27-nation European Union, according to exporters.

Obesity Drug Can't Be Advertised Anymore

Obesity Drug Can't Be Advertised Anymore

Rediff.com12 Mar 2026

'Any promotional activity carried out under the pretext of disease awareness, influencer engagement, corporate campaigns, or similar activities that create brand recall/product visibility of the prescription shall also be treated as violations.'

Stock Markets Today: Sensex, Nifty Tumble as West Asia Conflict & PM Modi's Austerity Appeal Spook Investors

Stock Markets Today: Sensex, Nifty Tumble as West Asia Conflict & PM Modi's Austerity Appeal Spook Investors

Rediff.com11 May 2026

Indian stock markets experienced a significant sell-off, with the Sensex tumbling over 1,300 points, driven by escalating crude oil prices due to US-Iran tensions and Prime Minister Narendra Modi's call for austerity measures, which amplified investor concerns about India's economic outlook.

India's M&A market resilient, poised for $200 billion annual run-rate

India's M&A market resilient, poised for $200 billion annual run-rate

Rediff.com11 May 2026

India's mergers and acquisitions (M&A) market is projected to maintain an annual run-rate of approximately $200 billion, evenly split between domestic, inbound, and outbound transactions, despite global geopolitical turbulence, according to Rajesh Singhi, global co-head, M&A Advisory, Standard Chartered Bank.

Sensex rises 329 pts on rally in pharma, banking shares

Sensex rises 329 pts on rally in pharma, banking shares

Rediff.com10 Oct 2025

Among the Sensex firms, State Bank of India, Maruti Suzuki India, Axis Bank, NTPC, BEL, Adani Ports, Eternal, Sun Pharmaceuticals, Power Grid, ITC, UltraTech Cement, Trent, HCL Technologies, Mahindra & Mahindra, and HDFC Bank were the major gainers. On the other hand, Tata Steel, Tata Consultancy Services, Tech Mahindra, Titan, Bajaj Finserv, Tata Motors, Bharti Airtel and Bajaj Finance were among the laggards.

Stock Markets Today: Sensex, Nifty50 Dive as Oil Prices Surge, Foreign Funds Exit

Stock Markets Today: Sensex, Nifty50 Dive as Oil Prices Surge, Foreign Funds Exit

Rediff.com24 Apr 2026

Indian benchmark indices Sensex and Nifty experienced a significant tumble in early trade, driven by surging global oil prices, continuous outflows by Foreign Institutional Investors (FIIs), and persistent geopolitical uncertainties, particularly in West Asia.

Abbott Bets On Semaglutide Boom

Abbott Bets On Semaglutide Boom

Rediff.com28 Feb 2026

Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.

Lukkhe Review: Familiar Drugs And Deceit Tale

Lukkhe Review: Familiar Drugs And Deceit Tale

Rediff.com8 May 2026

Lukkhe plunges into Chandigarh's dark underbelly, exploring a drug epidemic, political corruption, and a burgeoning rap scene, though its narrative often feels like a familiar crime drama, notes Deepa Gahlot.

Sensex, Nifty Extend Losses as Surging Oil Prices and IT Sell-off Hit Markets

Sensex, Nifty Extend Losses as Surging Oil Prices and IT Sell-off Hit Markets

Rediff.com24 Apr 2026

Indian equity benchmark indices Sensex and Nifty tumbled over 1 per cent for the third consecutive day, driven by a sharp rally in crude oil prices, massive selling in IT stocks, and unabated foreign fund outflows amid ongoing geopolitical tensions in the Middle East.

Patients to benefit from GST cut, but pharma firms may face margin pressure

Patients to benefit from GST cut, but pharma firms may face margin pressure

Rediff.com12 Sep 2025

The rationalisation of goods and services tax (GST), announced on Wednesday, directly lowers the cost of everyday medical consumables, and also high-end therapies in oncology and rare diseases, helping reduce out-of-pocket patient expenditure and better adherence to medication.

Indian Markets Extend Losses as Crude Oil Breaches $100 Amid US-Iran Standoff

Indian Markets Extend Losses as Crude Oil Breaches $100 Amid US-Iran Standoff

Rediff.com23 Apr 2026

Indian stock markets experienced a second consecutive day of losses, with the Sensex tumbling 852 points, as crude oil prices surpassed USD 100 per barrel due to stalled US-Iran negotiations and escalating geopolitical tensions in West Asia.

Stock Markets Today: Sensex, Nifty50 Tumble as Brent Crude Breaches $100

Stock Markets Today: Sensex, Nifty50 Tumble as Brent Crude Breaches $100

Rediff.com23 Apr 2026

Indian equities on Dalal Street saw volatility as global market trends and oil price hike impacted investor sentiment. Track Sensex, Nifty50 movement and key market drivers for Apr 23, 2026.

Oil Price Surge, FII Outflows Drag Indian Stock Markets Lower

Oil Price Surge, FII Outflows Drag Indian Stock Markets Lower

Rediff.com28 Apr 2026

Indian benchmark indices Sensex and Nifty experienced declines due to a sharp rally in crude oil prices, continuous foreign fund outflows, and geopolitical uncertainties. Regulatory developments in the banking sector, particularly the implementation of the Expected Credit Loss (ECL) framework, also contributed to the selling pressure.

JPMorgan downgrades Indian equities to 'neutral'

JPMorgan downgrades Indian equities to 'neutral'

Rediff.com25 Apr 2026

JPMorgan has downgraded Indian equities to 'neutral' from 'overweight', citing elevated valuations, rising earnings risks, and limited exposure to next-generation technology like AI. The brokerage believes other emerging markets offer more attractive risk/reward propositions despite India's strong structural growth story.

Two months of West Asia war: Analysts see smallcap's outperformance continuing

Two months of West Asia war: Analysts see smallcap's outperformance continuing

Rediff.com29 Apr 2026

Despite geopolitical tensions and FII outflows, Indian small and midcap stocks have not only recovered losses but are also outperforming largecap indices, driven by attractive valuations, domestic institutional support, and a rebound in earnings.

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Rediff.com31 Jul 2025

India's pharmaceuticals and medical devices industries are still hopeful that trade negotiations with the US could cut a fairer deal for both sides, after President Donald Trump announced a 25 per cent tariff rate on India on a social networking platform without divulging the finer details.

Sensex and Nifty Rally as Oil Prices Drop and Global Markets Recover

Sensex and Nifty Rally as Oil Prices Drop and Global Markets Recover

Rediff.com7 Apr 2026

Indian stock market benchmarks Sensex and Nifty closed higher on Tuesday, buoyed by a drop in crude oil prices, a rally in global markets, and strong buying in IT stocks.

Stock Markets Rally: Sensex Climbs 500 Pts Amid Easing Geopolitical Tensions

Stock Markets Rally: Sensex Climbs 500 Pts Amid Easing Geopolitical Tensions

Rediff.com17 Apr 2026

Indian benchmark indices Sensex and Nifty rallied nearly 1 per cent, driven by optimism over easing geopolitical tensions in the Middle East and fresh foreign fund inflows, with the Sensex gaining over 500 points.

Stock Market Today Feb 27, 2026 ' Sensex tanks 961 points, Nifty50 Fall 1.25%

Stock Market Today Feb 27, 2026 ' Sensex tanks 961 points, Nifty50 Fall 1.25%

Rediff.com27 Feb 2026

Benchmark indices Sensex and Nifty experienced a significant decline, falling over 1 per cent due to foreign fund outflows and global uncertainties.

Stock Markets Today: Sensex, Nifty50 Surge on Gains in Banking Stocks

Stock Markets Today: Sensex, Nifty50 Surge on Gains in Banking Stocks

Rediff.com10 Apr 2026

Indian markets on Dalal Street rallied sharply as easing tensions in the US-Iran conflict and stable oil prices boosted sentiment. Track Nifty 50 and BSE Sensex performance and key global triggers.

Indian pharma firms not copying products of Swiss cos: Goyal

Indian pharma firms not copying products of Swiss cos: Goyal

Rediff.com10 Jun 2025

Dismissing allegations that Indian phacosrmaceutical companies copy products of Swiss firms, Commerce and Industry Minister Piyush Goyal on Tuesday said it is a long-standing myth and India respects intellectual property rights and never steals technology from others. He said that Swiss pharmaceutical companies have not shown even a single instance that Indian companies have illegally copied any of their trademarks or patents or copyrighted technology.

Healthcare Funds: Caution Advised

Healthcare Funds: Caution Advised

Rediff.com12 Feb 2026

Most first-time investors may be better served by diversified options such as flexicap or multi-cap funds, which already hold pharma and healthcare stocks.

'Biggest Single Danger Is If Remittances Come Down'

'Biggest Single Danger Is If Remittances Come Down'

Rediff.com13 May 2026

'At the first sign of real trouble, that money will move. There will be a run.'

Stock Market Today: Sensex, Nifty50 Dip on High Crude Price

Stock Market Today: Sensex, Nifty50 Dip on High Crude Price

Rediff.com6 Apr 2026

Indian equities on Dalal Street declined in early trade on Monday as crude oil prices climbed amid fears of further escalation in the West Asia the war. Track Sensex, Nifty50 movement and key market drivers for Apr 6, 2026.

Industrial credit growth may clock 9-13% in H1CY26

Industrial credit growth may clock 9-13% in H1CY26

Rediff.com20 Apr 2026

The Indian banking sector is projected to experience a steady 9-13 per cent industrial credit growth in the first half of 2026, driven by capital expenditure, infrastructure development, and sectoral demand recovery, according to a Ficci-IBA survey.

Nomura, Citi slash year-end Nifty 50 target

Nomura, Citi slash year-end Nifty 50 target

Rediff.com17 Mar 2026

Foreign brokerages have started to cut their year-end targets for the Nifty 50 index amid the ongoing West Asia conflict.

Weak guidance may hit Sun Pharma in FY26

Weak guidance may hit Sun Pharma in FY26

Rediff.com1 Jun 2025

Despite a healthy performance in the fourth quarter of 2024-25 (Q4FY25), the stock of India's largest listed pharma company, Sun Pharmaceutical Industries (Sun Pharma), was under pressure on Friday due to a muted guidance. The company has guided for a high single-digit revenue growth for FY26, which is below what the Street was working with.

Sensex and Nifty Recover as Crude Oil Prices Dip and Bank Stocks Rally

Sensex and Nifty Recover as Crude Oil Prices Dip and Bank Stocks Rally

Rediff.com6 Apr 2026

Indian benchmark indices Sensex and Nifty rebounded sharply on Monday, driven by a correction in crude oil prices due to ceasefire efforts in West Asia and strong buying in bank stocks.

Hyderabad claims its place as global MNC destination

Hyderabad claims its place as global MNC destination

Rediff.com18 Feb 2026

Hyderabad is rapidly emerging as a strategic hub for multinational companies (MNCs) deepening their focus on artificial intelligence (AI), life sciences, and global capability centres (GCCs), supported by the city's strong pharmaceutical (pharma) base, deeptech talent pool, and a policy environment that encourages high-value investment.

Sensex and Nifty Rally as US-Iran Ceasefire Boosts Global Markets

Sensex and Nifty Rally as US-Iran Ceasefire Boosts Global Markets

Rediff.com8 Apr 2026

Indian stock markets experienced a significant rally following the announcement of a US-Iran ceasefire, coupled with a drop in crude oil prices. The Sensex and Nifty both closed nearly 4 per cent higher, mirroring gains in global markets.